Mex3c activators comprise a category of chemical compounds that specifically target and enhance the activity of the Mex3c gene product, a member of the Mex3 family of RNA-binding proteins. Mex3c is characterized by its K homology (KH) domains, which are typical of proteins that bind to RNA, indicating a role in post-transcriptional regulation processes such as mRNA turnover, translation, and localization. The activation of Mex3c by these compounds can influence the protein's ability to bind RNA, potentially affecting the stability and translation of target mRNAs. The activators may function through a variety of mechanisms, such as allosteric modulation where the compound binds to a site distinct from the RNA-binding domain, causing a conformational change that increases the protein's affinity for RNA or its ability to interact with other proteins involved in RNA metabolism.
The design and development of Mex3c activators involve an intricate process of compound identification and optimization. Initially, chemical libraries can be screened for molecules that increase the activity of Mex3c. This screening can be conducted using in vitro assays that measure the binding efficiency of Mex3c to RNA or its ability to regulate the stability of specific mRNAs. Once promising activators are identified, they are typically subjected to a series of medicinal chemistry efforts to enhance their potency and selectivity for Mex3c. The SAR (structure-activity relationship) studies are crucial at this stage, as they help in refining the molecular structures of the compounds to improve their interaction with Mex3c. Additionally, detailed structural studies of Mex3c, preferably in the activated state, can provide insights into the binding sites and conformational changes associated with activation. Techniques such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy can be employed to gain high-resolution structural data, which is instrumental for the rational design of more effective Mex3c activators.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG-132 is a proteasome inhibitor that can increase the levels of ubiquitinated proteins. It might indirectly increase the substrate availability for Mex3c, thereby modulating its activity. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Epoxomicin is a selective proteasome inhibitor, like MG-132, and could indirectly influence Mex3c by increasing ubiquitinated protein levels. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA. This action could lead to altered stability of mRNAs that are substrates for Mex3c. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, potentially affecting gene expression patterns. Altered gene expression could change the cellular levels of proteins that interact with or regulate Mex3c. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can change chromatin structure and gene expression. It might indirectly affect Mex3c by altering the expression of genes encoding Mex3c or its interacting partners. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is another histone deacetylase inhibitor with effects similar to Trichostatin A. It could potentially influence Mex3c function by changing gene expression patterns. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 is a vacuolar H+ ATPase inhibitor that prevents acidification of lysosomes. It can influence protein degradation pathways, potentially impacting Mex3c activity. |